2024 Innovo iP900BP-B Bluetooth Fingertip Pulse Oximeter, Blood Oxygen Monitor with Free App, Plethysmograph, and Perfusion Index (Snowy White)
Original price was: $64.94.$39.99Current price is: $39.99.
Price: $64.94 - $39.99
(as of Jun 12, 2024 16:19:35 UTC – Details)
From the brand
US Patented
Is Discontinued By Manufacturer : No
Product Dimensions : 2.25 x 1.25 x 1.35 inches; 2.89 ounces
Item model number : iP900 Series
Batteries : 2 AAA batteries required. (included)
Date First Available : December 7, 2017
Manufacturer : Innovo
ASIN : B077ZJ1ZKZ
Country of Origin : China
Accurate and Reliable – The Innovo iP900BP-B Finger Pulse Oximeter is a premium model with an improved LED and sensor, allowing SpO2 and pulse rate measurement even at low blood perfusion.
Wireless Bluetooth Connection – Connect with your iPhone or Android via Bluetooth using the ‘Beyond Oximeter’ App. Record readings, visualize SpO2 Waveform, record respiration rate, and check Perfusion Index.
Patented Multi-Directional Display – Choose from 6 layout options for easy viewing of blood oxygen and pulse. Switch display orientation at the push of a button for user or caregiver.
Plethysmograph and Perfusion Index – Ensure accurate SpO2 and Pulse Rate readings. Eliminate doubts about reliability or reading issues.
Sports Enthusiasts, Aviation or Home Use – Ideal for climbers, skiers, bikers, aviators, and on-the-go SpO2 and pulse rate tracking. Use pre- or post- exercise, remaining still during measurement.
Customers say
Customers like the ease of use, performance, accuracy, quality and value of the blood oxygen monitor. They mention that it works well, provides accurate readings and is reliable. They also appreciate the size, appearance and display.
AI-generated from the text of customer reviews
User Reviews
Be the first to review “2024 Innovo iP900BP-B Bluetooth Fingertip Pulse Oximeter, Blood Oxygen Monitor with Free App, Plethysmograph, and Perfusion Index (Snowy White)”
Original price was: $64.94.$39.99Current price is: $39.99.
There are no reviews yet.